New article on prenatal exposure to benzodiazepines and z-hypnotics

New article by PharmaSafe researchers on the impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age. 

Image may contain: abdomen, stomach, trunk, mother, organ.

Photo: Coulorbox.com

Many women experience anxiety or sleep disorders during pregnancy and require pharmacological treatment with benzodiazepines or z-hypnotics.This study was based on The Norwegian Mother, Father and Child Cohort Study and The Medical Birth Registry of Norway. The final study population included data for 36 401 children. The results showed that prenatal exposure to these medications did not have an effect on behavioral problems at 5 years of age. 

Read the full article here.

Read an interview with PhD student Lene Maria Sundbakk in Dagens Medisin, and an article in Farmatid

Sundbakk LM, Wood M, Gran JM, Nordeng H (2019) Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study. PLOS ONE 14(6): e0217830. 

Published July 4, 2019 3:35 PM - Last modified July 10, 2019 2:56 PM